Literature DB >> 3133237

The effects of TRH analogues on cerebral ischaemia produced by middle cerebral artery occlusion in the rat.

J Shrewsbury-Gee1, R H Lye, A Latham, P Slater.   

Abstract

This study examined the effects of two stabilised analogues of TRH, RX 77368 and CG 3509, in a rat cerebral ischaemia model produced by unilateral occlusion of the middle cerebral artery. The analogues were given intraventricularly after artery occlusion. The extent of the cortical ischaemia was evaluated after 10 days by somatosensory evoked potential (SEP) recording, followed by tetrazolium staining of brain slices for NADH-diaphorase activity. RX 77368 (2 X 10 micrograms; 15 min, 24 h) significantly improved the survival rate, protected the SEP and reduced the area of infarct. In contrast, neither a smaller dose of RX 77368 (2 X 3 micrograms) nor a 4 h delay in the treatment had any significant beneficial effects. Although CG 3509 (2 X 10 micrograms) resulted in an apparent improvement in survival, its overall effects were not statistically significant. The findings indicate that stabilised TRH analogues may have beneficial effects when given to animals with focal cerebral ischaemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133237     DOI: 10.1007/bf00248359

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  50 in total

1.  Effects of TRH on cerebral and peripheral blood flows; role of submesencephalic brain stem centres.

Authors:  L O Koskinen
Journal:  Acta Physiol Scand       Date:  1986-10

2.  Is thyrotropin releasing hormone an endogenous ergotropic substance in the brain?

Authors:  G Metcalf; P W Dettmar
Journal:  Lancet       Date:  1981-03-14       Impact factor: 79.321

3.  Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.

Authors:  I Sobue; H Yamamoto; M Konagaya; M Iida; T Takayanagi
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

4.  Behavioral effects of hypothalamic hypophysiotropic hormones, neurotensin, substance P and other neuropeptides.

Authors:  C B Nemeroff; P W Kalivas; R N Golden; A J Prange
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

5.  Autoradiographic visualization of receptor binding sites for thyrotropin-releasing hormone in the rodent brain.

Authors:  J M Palacios
Journal:  Eur J Pharmacol       Date:  1983-08-19       Impact factor: 4.432

6.  Biologically stable analogues of TRH with increased neuropharmacological potency.

Authors:  D Brewster; P W Dettmar; G Metcalf
Journal:  Neuropharmacology       Date:  1981-05       Impact factor: 5.250

7.  Influence of thyrotropin releasing hormone (TRH) on drug-induced narcosis and hypothermia in rabbits.

Authors:  A Horita; M A Carino; R M Chesnut
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

8.  Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.

Authors:  W K Engel; T Siddique; J T Nicoloff
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

Review 9.  Regulatory peptides as a source of new drugs--the clinical prospects for analogues of TRH which are resistant to metabolic degradation.

Authors:  G Metcalf
Journal:  Brain Res       Date:  1982-11       Impact factor: 3.252

10.  Neuropharmacological evaluation of RX 77368--a stabilised analogue of thyrotropin-releasing hormone (TRH).

Authors:  G Metcalf; P W Dettmar; D Fortune; A G Lynn; I F Tulloch
Journal:  Regul Pept       Date:  1982-03
View more
  2 in total

1.  Protirelin tartrate (TRH-T) in upper motoneuron syndrome: a controlled neurophysiological and clinical study.

Authors:  C Civardi; P Naldi; R Cantello; M Gianelli; R Mutani
Journal:  Ital J Neurol Sci       Date:  1994-11

2.  Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum.

Authors:  Jean Lud Cadet; Michael T McCoy; Ning Sheng Cai; Irina N Krasnova; Bruce Ladenheim; Genevieve Beauvais; Natascha Wilson; William Wood; Kevin G Becker; Amber B Hodges
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.